For instance, NEAT1, MEG3, and MALAT1 lncRNA levels are higher in MASLD patients, with NEAT1 upregulated in both inflammatory MASLD and advanced fibrosis [37]. This evidence concerns the gene MEG3 and metabolic dysfunction-associated steatotic liver disease.